Medifast (MED) Depreciation and Depletion (2024 - 2026)

Medifast's Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• Quarterly Depreciation and Depletion rose 13.04% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (down 37.93% YoY) and the FY2025 annual result came in at $10.5 million, down 39.66% from the prior year.
• Depreciation and Depletion was $2.6 million for Q1 2026 at Medifast, roughly flat from $2.6 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $10.5 million in Q2 2024 and bottomed at $2.3 million in Q1 2024.
• A 3-year average of $3.4 million and a median of $2.5 million in 2025 frame the typical range for Depreciation and Depletion.
• Peak annual rise in Depreciation and Depletion reached 13.04% in 2025, while the deepest fall reached 70.48% in 2025.
• Medifast's Depreciation and Depletion stood at $2.3 million in 2024, then rose by 13.04% to $2.6 million in 2025, then changed by 0.0% to $2.6 million in 2026.
• Business Quant data shows MED's Depreciation and Depletion at $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.5 million in Q3 2025.